Sox4 is required for the survival of Pro-B cells

Journal of Immunology

Volumn 190, Issue 5, 2013, Pages 2080-2089

  Sun, Baohua ^a   Mallampati, Saradhi ^a   Gong, Yun ^a   Wang, Donghai ^b   Lefebvre, Véronique ^c   Sun, Xiaoping ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; PROTEIN BCL 2; PROTEIN TYROSINE KINASE; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR SOX4;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BCL2 GENE; BONE MARROW; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; CRE GENE; DEVELOPMENTAL STAGE; DISEASE SEVERITY; GENE DELETION; HEMATOPOIETIC STEM CELL; IMMUNE DEFICIENCY; LIVER; MOUSE; NONHUMAN; NULL ALLELE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SOX4 GENE; TRANSGENE;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; BCL-ASSOCIATED DEATH PROTEIN; BONE MARROW; CELL DIFFERENTIATION; CELL SURVIVAL; FETUS; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; INTEGRASES; LIVER; LYMPHOCYTE COUNT; MICE; MICE, KNOCKOUT; PIPERAZINES; PRECURSOR CELLS, B-LYMPHOID; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-KIT; PROTO-ONCOGENE PROTEINS PP60(C-SRC); PYRIMIDINES; SIGNAL TRANSDUCTION; SOXC TRANSCRIPTION FACTORS; TRANSGENES;

EID: 84874283550     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202736     Document Type: Article

References (59)

1. Kondo, M., I. L. Weissman, and K. Akashi. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91: 661-672.
2. Hardy, R. R., and K. Hayakawa. 2001. B cell development pathways. Annu. Rev. Immunol. 19: 595-621.
3. Nagasawa, T. 2006. Microenvironmental niches in the bone marrow required for B-cell development. Nat. Rev. Immunol. 6: 107-116.
4. Busslinger, M. 2004. Transcriptional control of early B cell development. Annu. Rev. Immunol. 22: 55-79.
5. Fuxa, M., and J. A. Skok. 2007. Transcriptional regulation in early B cell development. Curr. Opin. Immunol. 19: 129-136.
6. Arinobu, Y., S. Mizuno, Y. Chong, H. Shigematsu, T. Iino, H. Iwasaki, T. Graf, R. Mayfield, S. Chan, P. Kastner, and K. Akashi. 2007. Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages. Cell Stem Cell 1: 416-427.
7. Kirstetter, P., M. Thomas, A. Dierich, P. Kastner, and S. Chan. 2002. Ikaros is critical for B cell differentiation and function. Eur. J. Immunol. 32: 720-730.
8. Wang, J. H., A. Nichogiannopoulou, L. Wu, L. Sun, A. H. Sharpe, M. Bigby, and K. Georgopoulos. 1996. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5: 537-549.
9. Kikuchi, K., A. Y. Lai, C. L. Hsu, and M. Kondo. 2005. IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF. J. Exp. Med. 201: 1197-1203.
10. Miller, J. P., D. Izon,W. DeMuth, R. Gerstein, A. Bhandoola, and D. Allman. 2002. The earliest step in B lineage differentiation from common lymphoid progenitors is critically dependent upon interleukin 7. J. Exp. Med. 196: 705-711.
11. Polli, M., A. Dakic, A. Light, L. Wu, D. M. Tarlinton, and S. L. Nutt. 2005. The development of functional B lymphocytes in conditional PU.1 knock-out mice. Blood 106: 2083-2090.
12. O'Riordan, M., and R. Grosschedl. 1999. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 11: 21-31.
13. Sigvardsson, M., M. O'Riordan, and R. Grosschedl. 1997. EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes. Immunity 7: 25-36.
14. Nutt, S. L., B. Heavey, A. G. Rolink, and M. Busslinger. 1999. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401: 556-562.
15. Thévenin, C., S. L. Nutt, and M. Busslinger. 1998. Early function of Pax5 (BSAP) before the pre-B cell receptor stage of B lymphopoiesis. J. Exp. Med. 188: 735-744.
16. Matsuzaki, Y., K. Nakayama, K. Nakayama, T. Tomita, M. Isoda, D. Y. Loh, and H. Nakauchi. 1997. Role of bcl-2 in the development of lymphoid cells from the hematopoietic stem cell. Blood 89: 853-862.
17. Fang, W., D. L. Mueller, C. A. Pennell, J. J. Rivard, Y. S. Li, R. R. Hardy, M. S. Schlissel, and T. W. Behrens. 1996. Frequent aberrant immunoglobulin gene rearrangements in pro-B cells revealed by a bcl-xL transgene. Immunity 4: 291-299.
18. Kirman, I., K. Zhao, Y. Wang, P. Szabo, W. Telford, and M. E. Weksler. 1998. Increased apoptosis of bone marrow pre-B cells in old mice associated with their low number. Int. Immunol. 10: 1385-1392.
19. Vikstrom, I., S. Carotta, K. Lüthje, V. Peperzak, P. J. Jost, S. Glaser, M. Busslinger, P. Bouillet, A. Strasser, S. L. Nutt, and D. M. Tarlinton. 2010. Mcl-1 is essential for germinal center formation and B cell memory. Science 330: 1095-1099.
20. Lu, L., P. Chaudhury, and D. G. Osmond. 1999. Regulation of cell survival during B lymphopoiesis: apoptosis and Bcl-2/Bax content of precursor B cells in bone marrow of mice with altered expression of IL-7 and recombinase-activating gene-2. J. Immunol. 162: 1931-1940.
21. Jiang, A., and E. A. Clark. 2001. Involvement of Bik, a proapoptotic member of the Bcl-2 family, in surface IgM-mediated B cell apoptosis. J. Immunol. 166: 6025-6033.
22. Craxton, A., K. E. Draves, A. Gruppi, and E. A. Clark. 2005. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway. J. Exp. Med. 202: 1363-1374.
23. Dai, X., Y. Chen, L. Di, A. Podd, G. Li, K. D. Bunting, L. Hennighausen, R. Wen, and D. Wang. 2007. Stat5 is essential for early B cell development but not for B cell maturation and function. J. Immunol. 179: 1068-1079.
24. Malin, S., S. McManus, C. Cobaleda, M. Novatchkova, A. Delogu, P. Bouillet, A. Strasser, and M. Busslinger. 2010. Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development. Nat. Immunol. 11: 171-179.
25. Koralov, S. B., S. A. Muljo, G. R. Galler, A. Krek, T. Chakraborty, C. Kanellopoulou, K. Jensen, B. S. Cobb, M. Merkenschlager, N. Rajewsky, and K. Rajewsky. 2008. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132: 860-874.
26. Weston, M. D., M. L. Pierce, H. C. Jensen-Smith, B. Fritzsch, S. Rocha-Sanchez, K. W. Beisel, and G. A. Soukup. 2011. MicroRNA-183 family expression in hair cell development and requirement of microRNAs for hair cell maintenance and survival. Dev. Dyn. 240: 808-819.
27. Waskow, C., S. Paul, C. Haller, M. Gassmann, and H. R. Rodewald. 2002. Viable c-Kit(W/W) mutants reveal pivotal role for c-kit in the maintenance of lymphopoiesis. Immunity 17: 277-288.
28. Agosti, V., S. Corbacioglu, I. Ehlers, C. Waskow, G. Sommer, G. Berrozpe, H. Kissel, C. M. Tucker, K. Manova, M. A. Moore, et al. 2004. Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell development. J. Exp. Med. 199: 867-878.
29. Schepers, G. E., R. D. Teasdale, and P. Koopman. 2002. Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. Dev. Cell 3: 167-170.
30. Schilham, M. W., M. A. Oosterwegel, P. Moerer, J. Ya, P. A. de Boer, M. van de Wetering, S. Verbeek, W. H. Lamers, A. M. Kruisbeek, A. Cumano, and H. Clevers. 1996. Defects in cardiac outflow tract formation and pro-Blymphocyte expansion in mice lacking Sox-4. Nature 380: 711-714.
31. Bhattaram, P., A. Penzo-Méndez, E. Sock, C. Colmenares, K. J. Kaneko, A. Vassilev, M. L. Depamphilis, M. Wegner, and V. Lefebvre. 2010. Organogenesis relies on SoxC transcription factors for the survival of neural and mesenchymal progenitors. Nat Commun 1: 9.
32. Nissen-Meyer, L. S., R. Jemtland, V. T. Gautvik, M. E. Pedersen, R. Paro, D. Fortunati, D. D. Pierroz, V. A. Stadelmann, S. Reppe, F. P. Reinholt, et al. 2007. Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice. J. Cell Sci. 120: 2785-2795.
33. Potzner, M. R., K. Tsarovina, E. Binder, A. Penzo-Méndez, V. Lefebvre, H. Rohrer, M. Wegner, and E. Sock. 2010. Sequential requirement of Sox4 and Sox11 during development of the sympathetic nervous system. Development 137: 775-784.
34. Pramoonjago, P., A. S. Baras, and C. A. Moskaluk. 2006. Knockdown of Sox4 expression by RNAi induces apoptosis in ACC3 cells. Oncogene 25: 5626-5639.
35. Thein, D. C., J. M. Thalhammer, A. C. Hartwig, E. B. Crenshaw, III, V. Lefebvre, M. Wegner, and E. Sock. 2010. The closely related transcription factors Sox4 and Sox11 function as survival factors during spinal cord development. J. Neurochem. 115: 131-141.
36. Penzo-Méndez, A., P. Dy, B. Pallavi, and V. Lefebvre. 2007. Generation of mice harboring a Sox4 conditional null allele. Genesis 45: 776-780.
37. de Boer, J., A. Williams, G. Skavdis, N. Harker, M. Coles, M. Tolaini, T. Norton, K. Williams, K. Roderick, A. J. Potocnik, and D. Kioussis. 2003. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur. J. Immunol. 33: 314-325.
38. Domen, J., K. L. Gandy, and I. L. Weissman. 1998. Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood 91: 2272-2282.
39. Bustelo, X. R., S. D. Rubin, K. L. Suen, D. Carrasco, and M. Barbacid. 1993. Developmental expression of the vav protooncogene. Cell Growth Differ. 4: 297-308.
40. Georgiades, P., S. Ogilvy, H. Duval, D. R. Licence, D. S. Charnock-Jones, S. K. Smith, and C. G. Print. 2002. VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages. Genesis 34: 251-256.
41. Hardy, R. R., and K. Hayakawa. 1991. A developmental switch in B lymphopoiesis. Proc. Natl. Acad. Sci. USA 88: 11550-11554.
42. Balciunaite, G., R. Ceredig, S. Massa, and A. G. Rolink. 2005. A B220+ CD117+ CD19- hematopoietic progenitor with potent lymphoid and myeloid developmental potential. Eur. J. Immunol. 35: 2019-2030.
43. Rolink, A., E. ten Boekel, F. Melchers, D. T. Fearon, I. Krop, and J. Andersson. 1996. A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors. J. Exp. Med. 183: 187-194.
44. Rumfelt, L. L., Y. Zhou, B. M. Rowley, S. A. Shinton, and R. R. Hardy. 2006. Lineage specification and plasticity in CD192 early B cell precursors. J. Exp. Med. 203: 675-687.
45. Li, Y. S., R. Wasserman, K. Hayakawa, and R. R. Hardy. 1996. Identification of the earliest B lineage stage in mouse bone marrow. Immunity 5: 527-535.
46. Diao, J., E. Winter, W. Chen, C. Cantin, and M. S. Cattral. 2004. Characterization of distinct conventional and plasmacytoid dendritic cell-committed precursors in murine bone marrow. J. Immunol. 173: 1826-1833.
47. Pelayo, R., J. Hirose, J. Huang, K. P. Garrett, A. Delogu, M. Busslinger, and P. W. Kincade. 2005. Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow. Blood 105: 4407-4415.
48. Steff, A. M., M. Fortin, C. Arguin, and P. Hugo. 2001. Detection of a decrease in green fluorescent protein fluorescence for the monitoring of cell death: an assay amenable to high-throughput screening technologies. Cytometry 45: 237-243.
49. Jackson, S. M., and J. D. Capra. 2005. IgH V-region sequence does not predict the survival fate of human germinal center B cells. J. Immunol. 174: 2805-2813.
50. van Engeland, M., L. J. Nieland, F. C. Ramaekers, B. Schutte, and C. P. Reutelingsperger. 1998. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31: 1-9.
51. Dillon, S. R., M. Mancini, A. Rosen, and M. S. Schlissel. 2000. Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation. J. Immunol. 164: 1322-1332.
52. Meffre, E., and M. C. Nussenzweig. 2002. Deletion of immunoglobulin beta in developing B cells leads to cell death. Proc. Natl. Acad. Sci. USA 99: 11334-11339.
53. Reichlin, A., Y. Hu, E. Meffre, H. Nagaoka, S. Gong, M. Kraus, K. Rajewsky, and M. C. Nussenzweig. 2001. B cell development is arrested at the immature B cell stage in mice carrying a mutation in the cytoplasmic domain of immunoglobulin beta. J. Exp. Med. 193: 13-23.
54. Matsuda, K., M. Koguma, R. Okuyama, T. Nakazawa, Y. Matsuzaki, H. Nakauchi, N. Yanai, T. Terasaki, and M. Obinata. 1999. A novel stromal celldependent B lymphoid stem-like cell line that induces immunoglobulin gene rearrangement. J. Biochem. 125: 602-612.
55. Merino, R., L. Ding, D. J. Veis, S. J. Korsmeyer, and G. Nuñez. 1994. Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J. 13: 683-691.
56. Nakayama, K., K. Nakayama, I. Negishi, K. Kuida, H. Sawa, and D. Y. Loh. 1994. Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc. Natl. Acad. Sci. USA 91: 3700-3704.
57. Linnekin, D. 1999. Early signaling pathways activated by c-Kit in hematopoietic cells. Int. J. Biochem. Cell Biol. 31: 1053-1074.
58. Zhang, S., W. C. Huang, P. Li, H. Guo, S. B. Poh, S. W. Brady, Y. Xiong, L. M. Tseng, S. H. Li, Z. Ding, et al. 2011. Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways. Nat. Med. 17: 461-469.
59. Zhang, T., S. Liu, P. Yang, C. Han, J. Wang, J. Liu, Y. Han, Y. Yu, and X. Cao. 2009. Fibronectin maintains survival of mouse natural killer (NK) cells via CD11b/Src/beta-catenin pathway. Blood 114: 4081-4088.